Johnson Pharmacare
0.59
0.00(0.00%)
Market Cap₹32.50 Cr
PE Ratio-59.00
Company Performance:
1D0.00%
1M-1.67%
6M-32.18%
1Y-46.85%
5Y+118.52%
View Company Insightsright
More news about Johnson Pharmacare
12Mar 25
Johnson & Johnson Secures ₹3.34 Crore Victory in Delhi High Court Counterfeit Case
Johnson & Johnson has won a significant legal battle against counterfeit medical products in India. The Delhi High Court awarded J&J ₹3.34 crore in damages and issued a permanent injunction against the defendants for manufacturing and selling fake surgical products under J&J's trademarks. The court emphasized the public health risks posed by counterfeit medical products. This ruling reinforces J&J's brand protection efforts, commitment to patient safety, and sends a strong message to counterfeiters in the healthcare industry.
19Feb 25
Johnson & Johnson Faces Crucial Moment in $9 Billion Baby Powder Settlement
Johnson & Johnson is seeking approval for a $9 billion settlement to resolve lawsuits claiming its baby powder caused cancer. A lawyer representing 20,000 women is urging the court to approve the settlement. J&J's use of Chapter 11 bankruptcy strategy has faced opposition, including from the U.S. Trustee. The pre-bankruptcy voting process has also been questioned. If approved, this would be one of the largest mass tort litigation settlements in U.S. history, potentially allowing J&J to move past the controversy.
1 Year Returns:-46.85%
Industry Peers
Nesco
1,244.40
(+0.13%)
CMS Info Systems
350.50
(+2.55%)
SIS
334.65
(-0.98%)
Nirlon
500.00
(+0.05%)
Indiqube Spaces
203.60
(-2.42%)
Hemisphere Properties
137.62
(-0.51%)
Awfis Space Solutions
481.25
(-0.77%)